Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2017-03-13 2017-03-13
Drug Identification Number 00695033 00695033
Brand name SELAX SYR 20MG/5ML USP SELAX SYR 20MG/5ML USP
Common or Proper name Docusate Sodium Syrup, USP Docusate Sodium Syrup, USP
Company Name ODAN LABORATORIES LTD ODAN LABORATORIES LTD
Ingredients DOCUSATE SODIUM DOCUSATE SODIUM
Strength(s) 20MG 20MG
Dosage form(s) SYRUP SYRUP
Route of administration ORAL ORAL
Packaging size 250 mL 250 mL
ATC code A06AA A06AA
ATC description DRUGS FOR CONSTIPATION DRUGS FOR CONSTIPATION
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-04-15 2016-04-15
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments